openPR Logo
Press release

Multiplexed Diagnostic Market Driven By Innovation and Development of Technology

03-20-2018 09:01 AM CET | Health & Medicine

Press release from: CMI - Market Research Reports

Multiplexed Diagnostic Market Driven By Innovation

Mercodia has launched the AKURIO Islet Hormone multiplex assay with the collaboration of Quansys Bioscience in October 2017. This assay is designed to assess four different hormones in pancreatic study, which include glucagon, insulin, C-peptide, and proinsulin. AKURIO Islet Hormone multiplex assay provides high data accuracy with reliable speed. Moreover, Bruker has received CE-IVD marking for its Fungiplex Candida diagnostic assay in October 2017. Fungiplex Candida is based on real-time PCR and gives results in 2-3 hours of blood, plasma or serum sample by cutting the edge of additional cultural steps. Thereby, establishment of rapid detection assay in fungal infection allows the development of effective treatment strategies for improved patient outcomes.

The global multiplexed diagnostic market is estimated to be valued at US$ 8,698.0 in 2017 and is expected to witness a CAGR of 7.9% during the forecast period (2017 – 2025).

Ask for detailed Sample of the Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/983

*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it

Additionally, SpeeDx has received CE-IVD marking for its PlexPCR VHS Multiplex qPCR technology in October 2017. This diagnostic test is designed to detect and differentiate the four different genital and oral lesion viruses, which include herpes simplex virus types 1 and 2 (HSV-1 and -2), varicella-zoster virus (VZV), and Treponema pallidum (syphilis). Therefore, PlexPCR VHS Multiplex qPCR test is expected to provide early detection of infection and help in treatment decisions. Thus, advanced technology is expected to boost the growth of multiplexed diagnostic market during the forecast period.

According to Cancer Research UK, around 20 cases of ovarian cancers are diagnosed every day and it is projected to increase by around 15% from 2014 to 2035. Furthermore, according to American Cancer Society (ACS), in 2017, approximately 53,670 people are expected to be diagnosed with pancreatic cancer in the U.S. Moreover, according to Cancer Research UK, approximately 3,072 new cases were diagnosed with acute myeloid leukemia (AML) in 2014. As per Cancer Research U.K, Acute Myeloid Leukemia (AML) accounts approximately 8 cases per day. Increasing incidence of multiple cancers is expected to increase the demand for precise multiplexed diagnostic tools, in turn fueling the market growth.

Multiplexed diagnostics are used in investigation of biological samples, which are capable of completing a screening process with a single run. Multiplexed diagnostic assays are involved in the detection and diagnosis of different diseases and infections, which include cancers, autoimmune diseases, allergies, and cardiovascular diseases. Assays performed in multiplex diagnostics include high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays, and next-generation sequencing assays. Early diagnosis can minimize the risk factors associated with chronic diseases/infection and helps in proper treatment management. Moreover, multiplexed diagnostic assays have advantages, such as time efficiency and highly precise accuracy, which can analyze defects and mutations in any functional biomolecules (DNA, RNA, and protein).

To know more about the Multiplexed Diagnostic Market, click the link below: https://www.coherentmarketinsights.com/market-insight/multiplexed-diagnostic-market-983

According to the Centers for Disease Control and Prevention (CDC), 2014, around 236,968 women are diagnosed with breast cancer. Increasing demand for early diagnosis of infection/diseases needs rapid multiplexed diagnostic tools, which is expected to boost the growth of the multiplexed diagnostic market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplexed Diagnostic Market Driven By Innovation and Development of Technology here

News-ID: 984759 • Views: 656

More Releases from CMI - Market Research Reports

Bone Replacement Products Market– Effective Solution for Bone Problems
The innovative replacement systems are designed to provide patients with a joint preservation ultimatum, preserving the healthy parts of the knee, thus helping to maintain natural knee function. For instance, in 2014, Cayenne Medical launched the Mirror Partial Knee System, the only knee replacement system that uses the patient’s natural knee motion during the surgical procedure. This unique technology balances the knee throughout the entire range of motion. The
U.S. Influenza Vaccines Market– Prevention of Virus through Vaccination Aids i …
The government agencies in the U.S. are focusing on collaborations in order to increase the supply of influenza vaccines. For instance, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have partnered with the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support the advanced development of new and better influenza
Radiology Information System (RIS) Market: Market Competitive Situation and Tren …
North America is projected to witness high share in the radiology information system market, owing to the well-established healthcare infrastructure and early adoption of the advancement in the medical and healthcare industry in the U.S. Furthermore, Asia Pacific region is emerging region in radiology information system market, owing to the increasing investments on healthcare facilities and increasing demand for diagnosis and treatment of chronic disease. For instance, according to the
Immuno-Oncology Drugs Market is expected to witness a robust CAGR of 14.9% over …
The Global Immuno-oncology Drugs Market by Drug Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, and CAR-T Cell Therapy), by Cancer Type (Non-Small Cell Lung Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Breast Cancer, Ovarian Cancer, Prostate Cancer, Colorectal Cancer, Gastric Cancers, Glioblastoma, and Head & Neck Cancers), and by Region was valued at US$ 43,084.5 million in 2016 and is projected to exhibit a CAGR of 14.9%

All 5 Releases


More Releases for Multiplex

Multiplex Assay Market Regulations and Competitive Landscape Outlook to 2027
An assay which simultaneously measures multiple analytes in a single cycle of the assay is known as a multiplex assay. Within a given application area of technology, multiplex assays can further stratify the analytes which are measured per assay. The term multiplex refers to the highest number of analyte measurement per assay. Detection of the state of all biomolecules of a given class (i.e. proteins and mRNAs) within a
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assay Market : Opportunities, Demand and Forecasts, 2017 - 2027
An assay which simultaneously measures multiple analytes in a single cycle of the assay is known as a multiplex assay. Within a given application area of technology, multiplex assays can further stratify the analytes which are measured per assay. The term multiplex refers to the highest number of analyte measurement per assay. Detection of the state of all biomolecules of a given class (i.e. proteins and mRNAs) within a
Multiplex Assays Market - Niche Opportunities For Clients & Forecast 2017 - 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Value Projected to Expand by 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising